Ambeed.cn

首页 / / / / K02288

K02288 {[allProObj[0].p_purity_real_show]}

货号:A151373

K02288是一种I型BMP受体抑制剂,靶向ALK2、ALK1和ALK6,IC50分别为1.1、1.8和6.4 nM。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
K02288 化学结构 CAS号:1431985-92-0
K02288 化学结构
CAS号:1431985-92-0
K02288 3D分子结构
CAS号:1431985-92-0
K02288 化学结构 CAS号:1431985-92-0
K02288 3D分子结构 CAS号:1431985-92-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

K02288 纯度/质量文件 产品仅供科研

货号:A151373 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 ALK1 ALK2 ALK3 ALK4 ALK6 Smad3 TGF-β TGFβRI/ALK5 TGFβRII 其他靶点 纯度
LDN193189 ++++

ALK1, IC50: 0.8 nM

++++

ALK2, IC50: 0.8 nM

+++

ALK3, IC50: 5.3 nM

+++

ALK6, IC50: 16.7 nM

99%+
LDN-212854 ++++

ALK1, IC50: 2.4 nM

++++

ALK2, IC50: 1.3 nM

+

ALK3, IC50: 85.8 nM

+

ALK4, IC50: 2133 nM

+

ALK5, IC50: 9276 nM

99%+
ML347 ++

ALK1, IC50: 46 nM

++

ALK2, IC50: 32 nM

98%
K02288 ++++

ALK1, IC50: 1.8 nM

++++

ALK2, IC50: 1.1 nM

++

ALK3, IC50: 34.4 nM

+++

ALK6, IC50: 6.4 nM

99%+
LDN-193189 2HCl ++++

ALK1, IC50: 0.8 nM

++++

ALK2, IC50: 0.8 nM

+++

ALK3, IC50: 5.3 nM

+++

ALK6, IC50: 16.7 nM

99%
LDN-214117 ++

ALK2, IC50: 24 nM

98%
DMH-1 +

ALK2, IC50: 107.9 nM

99%+
SB-505124 +

ALK4, IC50: 129 nM

++

ALK5, IC50: 47 nM

99%+
Vactosertib +++

ALK4, IC50: 13 nM

+++

ALK5, IC50: 11 nM

99%+
Alantolactone 98%
(E/Z)-SIS3 free base 97%
Pirfenidone 98%
Hesperetin 97%
RepSox ++++

TGFβR1(ALK5), IC50: 4 nM

98%
GW788388 +++

ALK5, IC50: 18 nM

98%
LY364947 ++

TGFβRI, IC50: 59 nM

+

TGFβRII, IC50: 0.4 μM

98%
SD-208 ++

TGF-βRI (ALK5), IC50: 48 nM

99%
SB-525334 +++

TGFβR1(ALK5), IC50: 14.3 nM

99%+
LY2109761 ++

TβRI, Ki: 38 nM

+

TβRII, Ki: 300 nM

99%+
Galunisertib ++

TβRI, IC50: 56 nM

98%
SB 431542 +

ALK5, IC50: 94 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

K02288 生物活性

靶点
  • ALK1

    ALK1, IC50:1.8 nM

  • ALK2

    ALK2, IC50:1.1 nM

  • ALK6

    ALK6, IC50:6.4 nM

  • ALK3

    ALK3, IC50:34.4 nM

描述 Bone morphogenetic proteins (BMPs), members of the TGFβ superfamily, play an important role in stem cell biology and function to regulate cell proliferation and differentiation during development. BMPs initiate their signaling events through an interaction of their type I and type II receptors, both of which are transmembrane serine/threonine kinases. Seven type I receptors (a.k.a. activin receptor-like receptors; ALK1 to ALK7) and four type II receptors have been identified in mice and humans[3]. K02288 is a potent BMP type I receptor inhibitor with IC50s of 1.8, 1.1, 6.4 nM for ALK1, ALK2 and ALK6, respectively. K02288 also shows slightly weaker inhibition against ALK3 and ALK6 with IC50s of of 5-34 nM. Furthermore, K02288 further demonstrated an improved selectivity against ALK4 and ALK5 with IC50s of 321 nM and 302 nM, respectively. In C2C12 cells, the phosphorylation of Smad1/5/8, induced by BMP4, can be reduced by K02288 in a dose dependent manner with an apparent IC50 of 100 nM [4]. In LX-2 cells, the proliferation promotion effect of BMP9 stimulation was inhibited by incubating with 1μM of K02288 for 4 hours. In addition, the expression of pSMAD1/5, ID1, and α-SMA were significantly decreased by K02288 treatment[5]. On embryo development day 6, 100μl of K02288 (1μM) was deposited on the chick embryo chorioallantoic membrane (CAM) model. Four days later, a large fraction of the CAM models exhibited a distinctive phenotype of low vessel density reflecting the dysfunctional angiogenesis which occurs following hypersprouting[1].
作用机制 K02288 binds type I BMP receptor at the ATP-binding pocket. The 2-aminopyridine group of K02288 is an ATP-mimetic that binds the kinase hinge region of type I BMP receptor through two conserved hydrogen bonds[4].

K02288 细胞实验

Cell Line
Concentration Treated Time Description References
Huh7 cells 0.25 µM 5 days Suppressed not only ID1 and EpCAM expression Mol Oncol. 2021 Aug;15(8):2203-2218.
MT cells 0.25 µM 5 days Suppressed not only ID1 and EpCAM expression Mol Oncol. 2021 Aug;15(8):2203-2218.
Huh7 cells 1 µM 24 hours Suppressed the cell invasion/migration ability Mol Oncol. 2021 Aug;15(8):2203-2218.
MT cells 1 µM 24 hours Suppressed the cell invasion/migration ability Mol Oncol. 2021 Aug;15(8):2203-2218.
Lgr5+ CSCs 6.4 nM 3, 5, 7 days K02288 attenuated the radiosensitizing effect of PD on Lgr5+ CSCs, indicating that PD regulates the radiosensitivity of CSCs through the BMP signaling pathway Int J Biol Sci. 2019 Jan 1;15(2):430-440.
Human Umbilical Vein Endothelial Cells (HUVECs) 1 µM 30 minutes K02288 inhibited BMP9-induced phosphorylation of SMAD1/5/8, reducing both the SMAD and Notch-dependent transcriptional responses. Angiogenesis. 2015 Apr;18(2):209-17.
Abdominal preadipocytes 500 nM 30 minutes K02288 completely inhibited BMP2-induced SMAD1/5/8 phosphorylation Int J Obes (Lond). 2019 Dec;43(12):2458-2468.
Gluteal preadipocytes 500 nM 30 minutes K02288 completely inhibited BMP2-induced SMAD1/5/8 phosphorylation Int J Obes (Lond). 2019 Dec;43(12):2458-2468.
C2C12 1 nM to 10 µM 30 minutes Measure inhibition of BMP6-induced transcriptional activity (BRE-Luciferase) J Med Chem. 2014 Oct 9;57(19):7900-15.
HEK293T 1 nM to 10 µM 30 minutes Measure inhibition of TGF-β1-induced transcriptional activity (CAGA-Luciferase) J Med Chem. 2014 Oct 9;57(19):7900-15.
Human Umbilical Vein Endothelial Cells (HUVECs) 1 µM 4 hours K02288 treatment significantly downregulated BMP9 and Notch-dependent target gene expression. Angiogenesis. 2015 Apr;18(2):209-17.
Huh7 cells 0.5 µM 48 hours Suppressed the BMP9-induced upregulation of ID1 and EpCAM expression Mol Oncol. 2021 Aug;15(8):2203-2218.
NGT16 50 µM 72 hours To evaluate the effect of ALK2 inhibitor K02288 on NGT16 cell line, showing approximately 30% reduction in cell viability. Front Oncol. 2020 Jan 21;9:1568.
VSMCs 10 µM K02288 treatment abrogated the effect of TXNIP suppression on osteodifferentiation Circ Res. 2023 Jan 6;132(1):52-71.

K02288 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Chicken Chick Embryo Chorioallantoic Membrane (CAM) Model Topical Administration 100 µL Single dose, lasting 4 days K02288 caused dysfunctional vessel formation, characterized by hypersprouting and low vessel density. Angiogenesis. 2015 Apr;18(2):209-17.

K02288 参考文献

[1]Kerr G, Sheldon H, Chaikuad A, Alfano I, von Delft F, Bullock AN, Harris AL. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis. Angiogenesis. 2015 Apr;18(2):209-17

[2]Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN. A new class of small molecule inhibitor of BMP signaling. PLoS One. 2013 Apr 30;8(4):e62721.

[3]Luo J, Tang M, Huang J, He BC, Gao JL, Chen L, Zuo GW, Zhang W, Luo Q, Shi Q, Zhang BQ, Bi Y, Luo X, Jiang W, Su Y, Shen J, Kim SH, Huang E, Gao Y, Zhou JZ, Yang K, Luu HH, Pan X, Haydon RC, Deng ZL, He TC. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem. 2010 Sep 17;285(38):29588-98

[4]Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN. A new class of small molecule inhibitor of BMP signaling. PLoS One. 2013 Apr 30;8(4):e6272

[5]Li P, Li Y, Zhu L, Yang Z, He J, Wang L, Shang Q, Pan H, Wang H, Ma X, Li B, Fan X, Ge S, Jia R, Zhang H. Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis. Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):709-720.

K02288 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.84mL

0.57mL

0.28mL

14.19mL

2.84mL

1.42mL

28.38mL

5.68mL

2.84mL

K02288 技术信息

CAS号1431985-92-0
分子式C20H20N2O4
分子量 352.38
SMILES Code OC1=CC=CC(C2=CC(C3=CC(OC)=C(OC)C(OC)=C3)=C(N)N=C2)=C1
MDL No. MFCD26936347
别名
运输蓝冰
InChI Key CJLMANFTWLNAKC-UHFFFAOYSA-N
Pubchem ID 46173038
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, sealed in dry, 2-8°C

溶解方案

DMSO: 55 mg/mL(156.08 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。